文献速递脑血管病神经重症与神经感染

清醒镇静中使用右美托咪定与DEVT和RESCUE-BT试验中取栓卒中患者结局的关联

Association of Conscious Sedation With Dexmedetomidine and Outcome in Stroke Patients Undergoing Thrombectomy in the DEVT and RESCUE-BT Trials.
PubMed 文献 · Neurology · 2024-11-18

本研究为DEVT和RESCUE-BT两项多中心随机临床试验的个体患者水平汇总分析,纳入728例因颈内动脉或大脑中动脉闭塞行血管内治疗的患者,比较术中右美托咪定镇静与非右美托咪定镇静的结局。右美托咪定组功能独立率显著更低(40.3% vs 51.3%;aOR 0.66;95% CI 0.46-0.93;p=0.019),术中血流动力学不稳定发生率显著更高(9.7% vs 2.3%;aOR 4.60,95% CI 2.12-9.99,p<0.001)。

要点

  • 右美托咪定组90天功能独立率40.3%,非右美托咪定组51.3%,aOR 0.66(95% CI 0.46-0.93;p=0.019)。
  • 右美托咪定组术中血流动力学不稳定发生率9.7%,非右美托咪定组2.3%,aOR 4.60(95% CI 2.12-9.99;p<0.001)。
  • 亚组分析中,与局部麻醉或术中咪达唑仑相比,右美托咪定组结果相似。

核心结论

  • 在真实世界环境中,清醒镇静期间术中使用右美托咪定与接受血管内治疗的急性缺血性卒中患者功能结局呈负相关。
  • 作者认为需要更大队列验证该发现。

研究设计与样本

  • 本研究为RESCUE-BT和DEVT两项多中心随机临床试验的个体患者水平汇总分析。
  • 纳入因颈内动脉或大脑中动脉闭塞行血管内治疗的患者,共728例,其中女性308例(42.3%)。
  • 右美托咪定组为术中接受右美托咪定行清醒镇静者,非右美托咪定组为术中未接受右美托咪定镇静者。

主要发现

  • 中位(四分位距)年龄为69(59-76)岁,基线美国国立卫生研究院卒中量表评分中位数为16(12-19)。
  • 右美托咪定组功能独立(90天改良Rankin量表评分0-2分)率40.3%,非右美托咪定组51.3%,aOR 0.66(95% CI 0.46-0.93;p=0.019)。
  • 右美托咪定组术中血流动力学不稳定发生率9.7%,非右美托咪定组2.3%,aOR 4.60(95% CI 2.12-9.99;p<0.001)。
  • 亚组分析中,与局部麻醉或术中咪达唑仑治疗患者相比,术中右美托咪定治疗患者结果相似。

关键数值与推荐

  • 主要结局为90天功能独立,定义为改良Rankin量表评分0-2分。
  • 调整比值比(aOR)和95% CI通过逻辑回归模型获得。
  • 证据等级:本研究提供II级证据,表明急性缺血性卒中血管内治疗中使用右美托咪定与其他药物相比与更差结局相关。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 作者认为需要更大队列验证该发现。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Although dexmedetomidine (DEX) is widely administered during endovascular treatment (EVT) to enhance procedural adherence of patients with acute ischemic stroke (AIS) with large vessel occlusion, there is limited research on the association of DEX and outcomes among these patients. Hence, this study aimed to explore the safety and outcomes of DEX during conscious sedation (CS) in a real-world setting among patients undergoing EVT. METHODS: This study was an individual patient-level pooled analysis of 2 multicenter randomized clinical trials RESCUE-BT and DEVT. This study included patients who underwent EVT because of occlusion of the internal carotid artery or middle cerebral artery. The DEX group included those receiving intraprocedural DEX for CS, whereas the patients without intraprocedural DEX sedation were categorized into the non-DEX group. The primary outcome was functional independence (modified Rankin Scale score of 0-2 at 90 days). Adjusted odds ratio (aOR) and 95% CI were obtained by logistic regression models. RESULTS: A total of 728 patients were included in this study, of whom 308 (42.3%) were female. The median (interquartile range) age was 69 (59-76) years; the median baseline NIH Stroke Scale score was 16 (12-19). Compared with the non-DEX group, the DEX group had a significantly lower rate of functional independence (40.3% vs 51.3%; aOR 0.66; 95% CI 0.46-0.93; p = 0.019). There was a significantly higher rate of unstable procedural hemodynamics in the DEX group (9.7% vs 2.3%; aOR 4.60, 95% CI 2.12-9.99, p < 0.001). In subgroup analysis, similar results were found in intraprocedural DEX-treated patients when compared with local anesthesia or intraprocedural midazolam-treated patients, respectively. DISCUSSION: There was a negative association between procedural DEX administration during CS and functional outcomes in patients with AIS receiving EVT in a real-world setting. A larger cohort is warranted to validate our findings. CLASSIFICATION OF EVIDENCE: This study provides Class II evidence that the use of DEX during EVT of AIS is associated with a worse outcome compared with other agents.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Gong C, Huang J, Qiu Z, et al. Association of Conscious Sedation With Dexmedetomidine and Outcome in Stroke Patients Undergoing Thrombectomy in the DEVT and RESCUE-BT Trials. Neurology. 2024. PMID: 39556775. doi:10.1212/WNL.0000000000209953

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。